为儿童喘药物提供量身定制的坚持激励措施:一项随机临床试验
Chén C Kenyon1,2,3, William O Quarshie4, Rui Xiao3
1PolicyLab, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
JAMA pediatrics
|March 17, 2025
概括
财政激励措施改善了儿童吸入性喘药物的坚持,但干预结束后,这种效果消失了. 这凸显了金融激励对药物服药的暂时影响.
科学领域:
- 儿科健康 儿科健康
- 临床试验 临床试验
- 健康差异 在健康上的差异
背景情况:
- 不同的预防药物坚持有助于儿童喘的种族差异.
- 针对性坚持是改善少数民族儿童喘结果的关键.
研究的目的:
- 评估金融激励增强干预对吸入性喘预防药物的坚持的影响.
- 评估这种干预在高风险,主要是种族少数群体的儿科队列中.
主要方法:
- 一项随机临床试验,涉及5至12岁患有持续性喘的儿童.
- 干预包括每天的文字提醒,每周的反,以及对药物坚持的经济激励.
- 通过使用电子吸入器传感器在7个月的时间内 (3个月的干预,3个月的观察) 监测依从性.
主要成果:
- 整个干预组在干预期间,与活跃对照组相比,干预组的遵守率高出15个百分点.
- 在干预结束后的3个月观察阶段,在各组之间没有观察到显著的遵守差异.
- 该研究包括106名儿童,其中82%的人认为自己是非西班牙裔黑人.
结论:
- 经济激励增强的移动健康干预措施可以暂时改善儿童吸入预防药物的坚持.
- 在干预组件被移除后,对坚持的积极影响并没有持续下去.
- 调查结果表明,虽然激励措施可以促进遵守,但它们的长期影响需要进一步调查.
相关概念视频
Inhaled Medications
212
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
212
Antiasthma Drugs: Leukotriene Modifiers
213
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
213
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
206
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
206
Antiasthma Drugs: β2-Adrenoceptor Agonists
208
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
208
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K


